Keywords: Avibactam; Gram-negative bacteria; Carbapenem-resistant Enterobacteriaceae; Clinical response; Microbiological response; Safety;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Intra-abdominal infections; Antimicrobial resistance; Ceftolozane; Avibactam; Eravacycline; Plazomicin;
Keywords: age; avibactam; pharmacokinetics; sex;
Keywords: Avibactam; Ceftazidime; Japanese; Safety; Tolerability; Pharmacokinetics;
Keywords: Ceftaroline fosamil; Avibactam; Enterobacteriaceae; Breakpoint
Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations
Keywords: Avibactam; Aztreonam; Ceftazidime; Model; Pharmacodynamics; Pharmacokinetic; Simulation; Translation;
Imipenem-avibactam: a novel combination for the rapid detection of carbapenemase activity in Enterobacteriaceae and Acinetobacter baumannii by matrix-assisted laser desorption ionization-time of flight mass spectrometry
Keywords: Imipenem; Avibactam; MALDI-TOF; Antimicrobial resistance detection;
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
Keywords: Extended-spectrum β-lactamase; ESBL; β-Lactam; Avibactam; AmpC;
Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance
Keywords: Ceftazidime; Avibactam; Enterobacteriaceae; Porins; AmpC; Resistance; Ceftazidima; Avibactam; Enterobacterias; Porinas; AmpC; Resistencia;
New Drug ReviewCeftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
Keywords: avibactam; ceftazidime/avibactam; cephalosporin/β-lactamase inhibitor; MDR gram-negative organisms; carbapenemase-producing organisms;
In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations
Keywords: Antibiotic resistance; Avibactam; Ceftazidime–avibactam; Ceftaroline–avibactam; Aztreonam–avibactam
In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates
Keywords: Avibactam; Susceptibility; Pseudomonas aeruginosa; Enterobacteriaceae; Staphylococcus; Streptococcus;
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
Keywords: β-Lactamase; Avibactam; ESBL; Carbapenemase; Inhibitor-resistance;
Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds
Keywords: Avibactam; Ceftaroline; Diabetic foot infections; Bacteroides fragilis; Anaerobes; Finegoldia magna; MRSA
Infections à bacilles à Gram négatif résistants : nouvelles molécules, nouvelles associations
Keywords: Nouveaux antibiotiques; Ceftolozane; Avibactam; MK-7655; Plazomicine; Eravacycline; Brilacidine; New antibiotics; Ceftolozane; Avibactam; MK-7655; Plazomicin; Eravacycline; Brilacidin;
In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
Keywords: Avibactam; β-Lactamases; OXA-48; Gram-negative bacteria